ATE191502T1 - Corticotropinauslösefaktor-bindendes protein - Google Patents

Corticotropinauslösefaktor-bindendes protein

Info

Publication number
ATE191502T1
ATE191502T1 AT92904821T AT92904821T ATE191502T1 AT E191502 T1 ATE191502 T1 AT E191502T1 AT 92904821 T AT92904821 T AT 92904821T AT 92904821 T AT92904821 T AT 92904821T AT E191502 T1 ATE191502 T1 AT E191502T1
Authority
AT
Austria
Prior art keywords
crf
protein
proteins
residue
useful
Prior art date
Application number
AT92904821T
Other languages
English (en)
Inventor
Ellen Potter
Dominic P Behan
Wolfgang H Fischer
Elizabeth A Linton
Philip J Lowry
Wylie Walker Vale Jr
Original Assignee
Salk Inst For Biological Studi
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi, Univ Reading filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE191502T1 publication Critical patent/ATE191502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT92904821T 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein ATE191502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64134191A 1991-01-15 1991-01-15
PCT/US1992/000331 WO1992013074A1 (en) 1991-01-15 1992-01-13 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)

Publications (1)

Publication Number Publication Date
ATE191502T1 true ATE191502T1 (de) 2000-04-15

Family

ID=24571955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904821T ATE191502T1 (de) 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein

Country Status (6)

Country Link
EP (1) EP0568622B1 (de)
JP (1) JP3090684B2 (de)
AT (1) ATE191502T1 (de)
CA (1) CA2097424A1 (de)
DE (1) DE69230881T2 (de)
WO (1) WO1992013074A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464757A (en) * 1991-01-15 1995-11-07 The Salk Institute For Biological Studies DNA encoding CRF binding protein
US5587462A (en) * 1993-11-08 1996-12-24 The Salk Institute For Biological Studies Brain-derived membrane-associated CRF binding proteins
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
US5830866A (en) * 1994-09-12 1998-11-03 The Trustees Of The University Of Pennsylvania Corticotropin release inhibiting factor and methods of using same
JP2000500968A (ja) * 1995-11-14 2000-02-02 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・アインゲトラーゲナー・フェアアイン Ｃｒｆ類縁体およびｃｒｆレセプターの光親和性標識におけるそれらの使用
WO2012133119A1 (ja) * 2011-03-28 2012-10-04 長瀬産業株式会社 フェリチンの製造方法
WO2018132768A1 (en) * 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity
US11173992B2 (en) 2017-12-28 2021-11-16 Legionarus, Llc Buoyancy garment
US11471112B2 (en) 2018-11-21 2022-10-18 Legionarius, Llc Mobile application for wearable device
USD905935S1 (en) 2019-02-20 2020-12-29 Legionarius, Llc Shirt with back pocket

Also Published As

Publication number Publication date
EP0568622A1 (de) 1993-11-10
EP0568622B1 (de) 2000-04-05
JPH06504445A (ja) 1994-05-26
DE69230881D1 (de) 2000-05-11
CA2097424A1 (en) 1992-07-15
JP3090684B2 (ja) 2000-09-25
WO1992013074A1 (en) 1992-08-06
DE69230881T2 (de) 2000-11-16

Similar Documents

Publication Publication Date Title
Chinery et al. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat
EA200300845A1 (ru) Модифицированные антитела и способы применения
RU2003131330A (ru) Средства для лечения воспалительных кишечных заболеваний
IL212686A0 (en) Oligodendrocyte binding human monoclonal igm antibodies and compositions and uses thereof
ATE191502T1 (de) Corticotropinauslösefaktor-bindendes protein
ATE165980T1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
DE69835680D1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
ATE141288T1 (de) Melaninkonzentrierende hormone und dns die diese expremieren
JP2003534363A (ja) トランスジェニック非ヒト動物由来ヒト血清アルブミン含有化粧組成物
ATE297983T1 (de) Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1
DK0948536T3 (da) G-protein-koblet receptor med et forstörret extracellulært domæne
EA200300132A1 (ru) Стресс-белки и пептиды и способы их применения
NO962596L (no) Nytt tumorsupressorgen
Bocci What are the roles of interferons in physiological conditions?
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
Pivnik et al. Alteration of intraerythrocyte proteolytic degradation of hemoglobin during Hodgkin's disease
DE69712182T2 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
KR950003312A (ko) 연골세포 단백질
Roberts et al. Amino acids of turnip yellow mosaic virus.
HUBER et al. The primary structure of the hemoglobin of the electric eel (Electrophorus electricus).
Marhaug et al. Characterization of serum amyloid A (SAA) protein in the sheep
Jahn et al. 65 LIVER MEMBRANE AUTOANTIBODIES (LMA) IN CHRONIC HEPATITIS OF THE AUTOIIMUNE TYPE: CHARACTERIZATION OF THE TARGET ANTIGEN.
Forsberg et al. Abdominal Fat Biopsy for Characterization of the Major Amyloid Fibril Proteins by Amino Acid Sequence Analysis
DE10311106B4 (de) Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties